Haleos Labs Limited: SEBI Depositories Compliance Certificate for Q3 FY26
Haleos Labs Limited submitted a compliance certificate for Q3 FY26 as per SEBI regulations. The RT&TA confirmed timely processing of dematerialization requests and updating records for the period October 1 to December 31, 2025.
This is a standard regulatory filing confirming compliance with SEBI rules regarding share transfers and dematerialization. It does not provide new financial information or signal any significant change in the company's operations or outlook.
The announcement is a routine compliance filing related to SEBI regulations and does not contain any financial performance data or significant corporate actions that would impact the sentiment.
Haleos Labs Limited (formerly SMS Lifesciences India Limited) has submitted a compliance certificate as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, received from their Registrar and Share Transfer Agent (RT&TA), M/s. Aarthi Consultants Private Limited, pertains to the quarter ended December 31, 2025.
The RT&TA confirms that all actions required under the regulation, including the dematerialization, mutilation and cancellation of certificates, and updating the register of owners, were completed within 15 days of receiving the security certificates from depository participants for the period from October 1, 2025, to December 31, 2025. The securities are listed on the stock exchanges where the original securities were issued.
The company has disseminated this information to BSE Limited and the National Stock Exchange of India Limited for record and further distribution to all concerned parties. The registered office of Haleos Labs Limited is located in Hyderabad, Telangana.
What to do with a filing like this
HALEOS LABS LIMITED filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by HALEOS LABS LIMITED. Read the original for the full detail.